Atlas Trials

AIDS Dementia Complex

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch AIDS Dementia Complex

RecordFirmDate
Maraviroc and NeuroAIDS Pathogenesis (NCT02159027)University of Hawaii2015-06-01
Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS (NCT02678767)Beau Nakamoto2015-02-01
Effect of Cenicriviroc on HIV Neurocognitive Impairment (NCT02128828)University of Hawaii2014-04-01
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD) (NCT00459693)National Institute of Mental Health (NIMH)2007-04-09
A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC) (NCT00000867)National Institute of Allergy and Infectious Diseases (NIAID)1996-12-01
A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases (NCT00002044)Glaxo Wellcome
An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts (NCT00000709)National Institute of Allergy and Infectious Diseases (NIAID)
Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy (NCT00002209)Centaur Pharmaceuticals
Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex (NCT00000657)National Institute of Allergy and Infectious Diseases (NIAID)
A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection (NCT00000702)National Institute of Allergy and Infectious Diseases (NIAID)
Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1 (NCT00000738)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex (NCT00002163)Glaxo Wellcome

Track AIDS Dementia Complex automatically

Every clearance here is in the API, with alerts when new ones post.